Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Change in Management Control
Aspira Pathlab appointed Mr. Vaibhav Odhekar as an Additional Executive Director for five years, effective May 23, 2026. He is a seasoned entrepreneur with over two decades of experience in technology-led platform businesses.
May 23 2026 19:47:06
Aspira Pathlab & Diagnostics Ltd - 540788 - Appointment Of M/S. Vishal J Bhanushali & Associates, Practicing Chartered Accountant (Firm Registration Number: 145806W), Having Membership No. 179979, As An Internal Auditor Of The Company For The Financial Year 2026-2027.
Aspira Pathlab has appointed Vaibhav Odhekar as an Additional Executive Director for a five-year term, subject to shareholder approval. The company also appointed Mrs. Neetu Maurya as Company Secretary and Compliance Officer, and M/s. Vishal J Bhanushali & Associates as Internal Auditor for FY 2026-27.
May 23 2026 19:44:28
Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Outcome For Outcome Of The Board Meeting Dated May 23, 2026
Aspira Pathlab's Board approved FY26 audited financial results, along with the appointments of Mrs. Neetu Maurya as Company Secretary & Compliance Officer and Mr. Vaibhav Odhekar as Additional Executive Director. The Board also appointed M/s. Vishal J Bhanushali & Associates as Internal Auditor for FY2026-27.
May 23 2026 18:58:27
Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Outcome for Outcome Of The Board Meeting Dated May 23, 2026
Aspira Pathlab's Board approved Q4 FY26 results showing a net loss of ₹68.91 lakhs and full-year FY26 net profit of ₹5.13 lakhs. The company also appointed Neetu Maurya as Company Secretary & Compliance Officer, M/s. Vishal J Bhanushali & Associates as Internal Auditor, and Vaibhav Odhekar as Additional Executive Director for five years, and acquired Om Pathology Laboratory.
May 23 2026 18:55:26
Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Approval Of Audited Standalone Financial Results Of The Company Along With The Auditor Report As On March 31, 2026
Aspira Pathlab & Diagnostics board will convene on May 23, 2026, to consider and approve the audited standalone financial results for the fourth quarter and the full financial year ended March 31, 2026. They will also address other business matters.
May 18 2026 20:16:20
Read More